Financial Snapshot

Revenue
$557.00
TTM
Gross Margin
42.81%
TTM
Net Earnings
-$124.8K
TTM
Current Assets
Current Liabilities
Current Ratio
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$19.24K
Q3 2024
Cash
Q3 2024
P/E
-158.7
Nov 11, 2024 EST
Free Cash Flow

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019
Revenue $2.340K $47.80K $15.97K $0.00 $0.00
YoY Change -95.1% 199.37%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019
Revenue $2.340K $47.80K $15.97K $0.00 $0.00
Cost Of Revenue $1.232K $22.61K $7.579K $0.00 $0.00
Gross Profit $1.108K $25.19K $8.388K $0.00 $0.00
Gross Profit Margin 47.35% 52.69% 52.53%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019
Selling, General & Admin $118.0K $1.010M $126.7K $6.368K $0.00
YoY Change -88.32% 697.67% 1888.93%
% of Gross Profit 10649.82% 4011.32% 1509.95%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $118.0K -$1.010M $126.7K $6.368K $0.00
YoY Change -111.68% -897.67% 1888.93%
Operating Profit -$116.9K -$985.1K -$118.3K -$6.368K $0.00
YoY Change -88.13% 732.95% 1757.21%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $8.00 $1.286K $44.00
YoY Change -100.0% -99.38% 2822.73%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019
Pretax Income -$116.9K -$985.1K -$118.3K -$6.368K $0.00
YoY Change -88.13% 732.95% 1757.21%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$116.9K -$985.1K -$117.0K -$6.324K $0.00
YoY Change -88.13% 742.1% 1749.79%
Net Earnings / Revenue -4995.51% -2060.87% -732.64%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$0.01 $0.00 $0.00 $0.00

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019
Cash & Short-Term Investments $53.23K $46.00K $210.0K $250.0K $250.0K
YoY Change 15.72% -78.1% -16.0% 0.0%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $174.8K $176.1K $200.0K
Prepaid Expenses
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $228.1K $222.1K $410.0K $250.0K $250.0K
YoY Change 2.71% -45.84% 64.0% 0.0%
Property, Plant & Equipment $0.00 $26.35K $50.00K
YoY Change -100.0% -47.3%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00 $0.00
YoY Change
Total Long-Term Assets $0.00 $26.35K $50.00K $0.00 $0.00
YoY Change -100.0% -47.3%
Total Assets $228.1K $248.4K $460.0K $250.0K $250.0K
YoY Change
Accounts Payable $0.00 $110.0K
YoY Change -100.0%
Accrued Expenses $0.00 $25.37K $50.00K $0.00 $0.00
YoY Change -100.0% -49.26%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.410K $26.78K $160.0K $0.00 $0.00
YoY Change -94.73% -83.26%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $141.9K $20.00K $0.00
YoY Change 609.6%
Total Long-Term Liabilities $141.9K $20.00K $0.00 $0.00 $0.00
YoY Change 609.6%
Total Liabilities $143.3K $46.78K $160.0K $0.00 $0.00
YoY Change 206.39% -70.76%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $19.8 Million

About GOLDENWELL BIOTECH, INC.

Goldenwell Biotech, Inc. is a development stage company. The company is headquartered in Hudson, Ohio. The company went IPO on 2021-12-07. The firm is offering its products under two categories: Polypeptide Freeze-dried Powder and Solid Tablets Products. The Company’s products are JI MAI-Bovine Cardiac Vascular Active Peptide, Double Proline AG- three-dimensional (3D) Active Collagen Peptide, Cartilage Peptide-Type II collagen peptide, Se Plus, and Sugar Master. Bovine cardiac vascular active peptide is a protein peptide of vascular homology (amino acid type and its sequence) which made from healthy and fresh bovine cardiac vascular tissues as raw materials. Its DPAG product is designed to be an easily absorbed bioactive collagen. Type II collagen peptide is prepared from Bovine or Pig Cartilage bones by hot water extraction. Its Sugar Master product is made utilizing low temperature extraction techniques to maximize the harvest of bio-actives of plant matter.

Industry: Food and Kindred Products Peers: